Anika Therapeutics, Inc. - 8-K Filing
Anika Therapeutics entered into a $50M senior revolving credit facility with Bank of America under Fifth Amendment on July 10, 2026. (Items: 1.01 Entry into a Material Definitive Agreement On July 10, 2026, we entered into a Fifth Amendment to Credit Agreement, or the Fifth Amendment, a, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 9.01 Financial Statements and Exhibits)
Tickers: $ANIK